Drugs / Nicoderm
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT01480232 | Dec 2011 → Sep 2015 | nicotine dependence | A. Eden Evins | Terminated | No outcome recorded |
| Phase 2 | NCT00469885 | Jan 2001 → Dec 2005 | cardiovascular disorder, nicotine dependence | National Institute on Drug Abuse (NIDA) | Completed | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT06554873 | Aug 2024 → Dec 2025 | — | Rose Research Center, LLC | Completed | No outcome recorded |
| Phase 3 | NCT06088862 | Dec 2023 → Apr 2024 | — | Rose Research Center, LLC | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 4 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nicoderm | “Nicoderm, Nicorrette” NCT00469885 ↗ |
| Route | Other | “One NicoDerm patch once daily for first 6 weeks (42 days).” NCT01480232 ↗ |